Home/Filings/4/0001415889-22-008937
4//SEC Filing

GIN JERRY B 4

Accession 0001415889-22-008937

CIK 0001411685other

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 5:12 PM ET

Size

8.3 KB

Accession

0001415889-22-008937

Insider Transaction Report

Form 4
Period: 2022-08-18
GIN JERRY B
Director
Transactions
  • Purchase

    Common Stock

    2022-08-18$0.18/sh+100,000$17,870100,000 total(indirect: By Spouse)
  • Purchase

    Common Stock

    2022-08-18$0.18/sh+100,000$17,870100,000 total
Holdings
  • Common Stock

    (indirect: By LLC)
    100,000
  • Common Stock

    (indirect: By LLC)
    100,000
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1772 to $0.1805, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  • [F2]Jermax, LLC is wholly owned and controlled by the Reporting Person.
  • [F3]Pegmax, LLC is wholly owned and controlled by the Reporting Person's spouse.

Issuer

VistaGen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1
  • filerCIK 0000901014

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 5:12 PM ET
Size
8.3 KB